The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimata, H.
Right arrow Articles by Mikawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimata, H.
Right arrow Articles by Mikawa, H.

The Journal of Immunology, Vol 150, Issue 10 4630-4640, Copyright © 1993 by American Association of Immunologists


ARTICLES

Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients

H Kimata, A Yoshida, M Fujimoto and H Mikawa
Department of Pediatrics, Faculty of Medicine, Kyoto University Hospital, Japan.

The effect of vasoactive intestinal peptide (VIP), somatostatin (SOM), and substance P (SP) on spontaneous human IgE and IgG4 production in atopic patients was studied. In cultures of mononuclear cells (MNC), VIP inhibited both IgE and IgG4 production without affecting IgM, IgA, IgG1, IgG2, or IgG3 production. In contrast, SOM inhibited only IgE production whereas SP inhibited only IgG4 production without affecting production of other isotypes or other IgG subclasses. The effect of neuropeptides was specific because each was specifically blocked by a corresponding neuropeptide antagonist. To achieve the effect noted above, neuropeptides must be added at the start of the culture. IFN- alpha and IFN-gamma were found to inhibit both IgE and IgG4 production whereas prostaglandin E2 (PGE2) inhibited only IgE production. However, the inhibition of IgE and IgG4 production by neuropeptides could not have been mediated by IFN-alpha, IFN-gamma, or PGE2 because the addition of anti-IFN-alpha, anti-IFN-gamma, and indomethacin, respectively, did not reverse the inhibition. In contrast to their effects on MNC, neuropeptides did not affect production of either IgE or IgG4 by purified B cells; the addition of either T cells or monocytes to B cells had no effect on this. However, neuropeptides were effective in inhibiting IgE and IgG4 production by B cells cultured together with both T cells and monocytes. Depletion of sIgE+ and sIgG4+ B cells resulted in abrogation of IgE and IgG4 production, respectively. However, stimulation of sIgE- B cells with IL-4 plus anti- CD 40 mAb induced IgE production, which was inhibited by VIP and SOM, but not SP, in the presence of both T cells and monocytes. These results suggest that neuropeptides inhibited spontaneous IgE and IgG4 production by interaction with sIgE+ and sIgG4+ B cells in a T cell- and monocyte-dependent fashion. In addition, VIP and SOM also inhibited IgE production by modulating switching induced by IL-4 plus anti-CD 40 mAb in a T cell- and monocyte-dependent fashion.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. N. Stan, J. A. Garrity, E. A. Bradley, J. J. Woog, M. M. Bahn, M. D. Brennan, S. C. Bryant, S. J. Achenbach, and R. S. Bahn
Randomized, Double-Blind, Placebo-Controlled Trial of Long-Acting Release Octreotide for Treatment of Graves' Ophthalmopathy
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4817 - 4824.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. Eskinazi
Homeopathy Re-revisited: Is Homeopathy Compatible With Biomedical Observations?
Arch Intern Med, September 27, 1999; 159(17): 1981 - 1987.
[Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Delneste, N. Herbault, B. Galea, G. Magistrelli, I. Bazin, J.-Y. Bonnefoy, and P. Jeannin
Vasoactive Intestinal Peptide Synergizes with TNF-{alpha} in Inducing Human Dendritic Cell Maturation
J. Immunol., September 15, 1999; 163(6): 3071 - 3075.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. C. Reubi, U. Horisberger, A. Kappeler, and J. A. Laissue
Localization of Receptors for Vasoactive Intestinal Peptide, Somatostatin, and Substance P in Distinct Compartments of Human Lymphoid Organs
Blood, July 1, 1998; 92(1): 191 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Paul, L. Li, R. Kalaga, P. Wilkins-Stevens, F. J. Stevens, and A. Solomon
Natural Catalytic Antibodies: Peptide-hydrolyzing Activities of Bence Jones Proteins and V[IMAGE] Fragment
J. Biol. Chem., June 23, 1995; 270(25): 15257 - 15261.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.